Navigation Links
Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program
Date:1/20/2011

ceived positive peer review and has obtained significant grant funding in its early development, and we are delighted to be the syndication lead in this financing round.  Alzheimer's affects 4.5 million people in the United States today, with that number expected to exceed 12 million by 2050."

Funds raised in this round will support preclinical work required for IND candidate selection, and enable Cognition Therapeutics to further exploit novel molecular targets and pathways identified through the company's phenotypic screens.    

"Our drug leads selectively block the activity of the toxic oligomeric form of Abeta protein that interferes with normal learning and memory," said Susan Catalano, Ph.D., Cognition Therapeutics Chief Science Officer.  "Studies from the world's leading academic laboratories indicate that the memory deficits caused by this oligomeric protein are among the earliest changes seen in Alzheimer's and Mild Cognitive Impairment, the precursor to Alzheimer's. These studies indicate that blocking the effects of this protein may halt or reverse Alzheimer's disease."  

Cognition has developed a number of screening strategies to identify small molecules capable of blocking the central toxicity of proteins in Alzheimer's disease and other neurodegenerative diseases. These assays emphasize phenotypic or functional responses of mature primary neurons to the toxic proteins. Cognition's proprietary chemistry platform converts natural product molecular scaffolds into low molecular weight chemically stable drug-like molecules, and is thus a source of novel pharmacophores and valuable drug candidates.

"The registration of the company's proprietary biological screening approach with positive results in an animal model of Alzheimer's disease is a significant achievement," said Dr. Cynthia Lemere, Associate Professor of Neurology at Harvard University's Brigham & Women's Hospital and member of Cognition's
'/>"/>

SOURCE Cognition Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Powerful Image Registration and Recognition Software Unveiled for Medical, Satellite, and Defense Imaging Industries
2. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
3. ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes
4. NeuroFocus Names John Polich, World-Renowned Scientist in Brain Function and Cognition, to Head Global NeuroLab Operations
5. Mayuka Labs R&D Centre Gets DSIR Recognition
6. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
7. Consistency, Flexibility Key in Improving Rewards & Recognition Programs
8. Precision Therapeutics Announces Two Pancreatic Cancer Studies Emphasizing the Utility of ChemoFx® in Cancer Treatment Options
9. Talecris Biotherapeutics Announces Revised Record Date and Meeting Date for Special Meeting of Shareholders
10. Aratana Therapeutics Announces $20 Million Financing
11. Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... Aug. 18, 2014 BioElectronics Corporation ... consumer medical devices said that its EVP ... by CEOLIVE.TV as part of its Executive ... is available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel ... to investors the unique advantages of BioElectronics ...
(Date:8/18/2014)... UPTON, NYElectronic devices with unprecedented efficiency and ... materials that use built-in electric polarizations to ... magnets inside most popular data-driven technology. But ... stumbling blocks, including a curious habit of ... at the U.S. Department of Energy,s Brookhaven ...
(Date:8/18/2014)... YORK , August 18, 2014 ... published by Transparency Market Research "Life Science Reagents ... Flow Cytometry, Electrophoresis, Chromatography, In-Vitro Diagnostic Reagents and ... and Academic Institutions, Clinical Laboratories, and Forensic Laboratories)- ... Forecast, 2013 - 2019", the global life science ...
(Date:8/18/2014)... Aug. 18, 2014 TNI BioTech, Inc. (OTC-BB: ... the manufacturing and marketing of innovative therapies for autoimmune ... is providing a second notice of TNI BioTech,s annual ... the announcement, Noreen Griffin , founder and CEO ... for your participation in the Annual Meeting. On behalf ...
Breaking Biology Technology:BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Promising ferroelectric materials suffer from unexpected electric polarizations 2Promising ferroelectric materials suffer from unexpected electric polarizations 3Promising ferroelectric materials suffer from unexpected electric polarizations 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 2TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 3TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 4
... (TSX: GEN),a company focused on developing molecular diagnostic ... early detection of diseases and personalized,health management, today ... design and development of in-vitro diagnostic (IVD) test,kits ... in a laboratory,setting, has met the requirements of ...
... Sweden, March 11 Mentice AB, a leading,supplier of ... has recently appointed James Ruscoe as Chairman of the ... Mr. Ruscoe graduated from Oxford University and brings ... He also serves as CEO and,board member of several ...
... March 11 Proteome Systems Ltd. (ASX: PXL),CEO ... a panel with world health,leaders in Washington DC ... the Bill & Melinda Gates Foundation and organised ... Biotechnology Industry Organization.,[March 10-12, 2008]., http://pgh.bio.org/opencms/PGH/2008/program/program.jsp , ...
Cached Biology Technology:GeneNews receives ISO 13485 accreditation 2Mentice AB Announces Leadership Changes Within Its Worldwide Operations 2The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems' CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C. 2The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems' CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C. 3
(Date:8/20/2014)... have discovered that acral melanomas the rare type of ... are genetically distinct from other more common types of skin ... the journal Pigment Cell & Melanoma Research . , ... soles of the feet, nail-beds and other hairless parts of ... not caused by UV damage from the sun. , The ...
(Date:8/20/2014)... rugs and plastic bags could one day be made ... petroleum, scientists are now reporting. The novel process they ... deal with its agricultural and plastic waste problems, appear ... Athanassiou, Ilker S. Bayer and colleagues at the Italian ... constantly growing. In 2012, its production reached 288 million ...
(Date:8/20/2014)... (PS1) absorbs light and its energy is finally ... biomass. Photovoltaic devices, mostly build from silicon based ... One approach for the development of cheaper and ... the isolated membrane protein complexes of photosynthesis. Prof. ... PS1 from thermophilic cyanobacteria that live in a ...
Breaking Biology News(10 mins):Scientists learn more about rare skin cancer that killed Bob Marley 2A semi-artificial leaf faster than 'natural' photosynthesis 2
... -- A new study led by Florida State University ... more flowers in response to only slight increases in ... clouds and rainfall affect the number of flowers that ... an effect over short-term seasonal growth, but longer-term changes ...
... Small and large-scale farmers in Riau province, Sumatra, have ... and parts of Malaysia. But scientists in Indonesia have ... buy unregulated access to land for oil palm and ... Scientists at the World Agroforestry Centre, who have been ...
... 8 July 2013: Egg donation is now one of ... treatment. Because this growing trend may circumvent regulations at ... also become one of the most controversial. Yet little ... eggs in overseas clinics - their characteristics, their motivation ...
Cached Biology News:Temperature increases causing tropical forests to blossom, according to study 2Less haze in Singapore as the cause becomes clearer and more complex 2Egg donation in European clinics: Why do women do it? 2Egg donation in European clinics: Why do women do it? 3
Endothelin-converting enzyme 1 (EC 3.4.24.71) (ECE-1). [Source:Uniprot/SWISSPROT;Acc:P42892] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
...
Red Standard is sodium salt of resorufin....
X-Gal, 100 mg. 5-Bromo-4-chloro-3-indolyl-b-d-galactoside.Histochemical substrate for b-galactosidase, used in blue/white screening.Store at -20 C. Protect from moisture. Category: Nucleotides & Enzy...
Biology Products: